Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Breast Cancer Research and Treatment|June 22, 2026
Receptor discordance between primary tumors and nodal metastases and correlation with the 21-gene recurrence score in early-stage, estrogen receptor-positive, node-positive breast cancerSerena Zheng, Peggy Sullivan, Kumkum Vadehra, et al.Journal of Immigrant and Minority Health|April 28, 2021
African Immigrants in New York City with Hepatitis B-Related Hepatocellular Carcinoma Demonstrate High Morbidity and MortalityJacquelyn Carr, Da Eun Cha, Tali Shaltiel, et al.Cancer|February 25, 2021
Hepatitis C-positive Black patients develop hepatocellular carcinoma at earlier stages of liver disease and present with a more aggressive phenotypeTali Shaltiel, Serena Zheng, Cleo Siderides, et al.The Journal of Surgical Research|March 4, 2023
T1 Gastric Cancer Is Associated With a High Incidence of Regional Lymph Node MetastasesSayed Imtiaz, Yael Berger, Elizabeth Gleeson, et al.Oncotarget|January 7, 2020
Single cell correlation analysis of liquid and solid biopsies in metastatic colorectal cancerAnna S Gerdtsson, Jana-Aletta Thiele, Stephanie N Shishido, et al.Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|February 5, 2026
Neoadjuvant Stereotactic Body vs. Conventionally Fractionated Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: A Propensity Score-Matched AnalysisTakayuki Shimizu, Serena Zheng, Shimpei Maeda, et al.Cancers|March 29, 2023
Outcomes of Patients with Positive Interim Positron Emission Tomography (PET) Continuing ABVD in the Clinical SettingSerena Zheng, Kanika Gupta, Piyush Goyal, et al.Cancers|August 12, 2023
Cell State and Cell Type: Deconvoluting Circulating Tumor Cell Populations in Liquid Biopsies by Multi-OmicsLisa Welter, Serena Zheng, Sonia Maryam Setayesh, et al.Haematologica|November 27, 2025
Mutational and copy number analysis at diagnosis and relapse of mantle cell lymphomaErel Joffe, Manik Uppal, Serena Zheng, et al.Nature Communications|January 31, 2026
Neoadjuvant modified FOLFIRINOX plus nivolumab in borderline-resectable pancreatic ductal adenocarcinoma: a pilot phase 1 trialZev A Wainberg, Jason M Link, Alykhan Premji, et al.Pageof 1